3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
5
Breast
2
Gynecologic
1
Genitourinary
1
Endocrine
1
Conditions
Multiple Endocrine Neoplasia Type 1
1
Hypertension
1
Colonic Neoplasms
1
Interventions
selpercatinib
3
Trastuzumab
2
Oxaliplatin
2
Melphalan
2
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
tipifarnib
1
sargramostim
1
repotrectinib
1
pralsetinib
1
mercaptoundecahydrododecaborate
1
entinostat
1
aldesleukin
1
Suramin
1
Rose Bengal
1
Ritonavir
1
Radiotherapy
1
Quality of Life
1
Patient Reported Outcome Measures
1
Patient Navigation
1
Paclitaxel
1
Molecular Diagnostic Techniques
1
Microscopy, Electron
1
Leucovorin
1
Interleukin-12 Subunit p35
1
Interleukin-12
1
Indinavir
1
Immunotherapy
1
Floxuridine
1
Fentanyl
1
Drug Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Patient Navigation
×
Endocrine
×
Clear all
NCT01092078
2015-04-22
MISTER-B
NYU Langone Health
Phase NA
Completed
740 enrolled